Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial

Shah, N. N., Wang, M., Roeker, L. E., Patel, K., Woyach, J. A., Wierda, W. G., Ujjani, C. S., Eyre, T. A., Inzani, P. L. Z., Alencar, A. J., Ghia, P., Lamanna, N., Hoffmann, M. S., Patel, M. R., Flinn, I., Gerson, J. N., Ma, S., Coombs, C. C., Cheah, C. Y., … Brown, J. R. (2024). Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial. Haematologica. https://doi.org/10.3324/haematol.2024.285754
Authors:
Nirav N Shah
Michael Wang
Lindsey E Roeker
Krish Patel
Jennifer A Woyach
William G Wierda
Chaitra S Ujjani
Toby A Eyre
Pier Luigi Zinzani
Alvaro J Alencar
Paolo Ghia
Nicole Lamanna
Marc S Hoffmann
Manish R Patel
Ian Flinn
James N Gerson
Shuo Ma
Catherine C Coombs
Chan Y Cheah
Ewa Lech-Maranda
Bita Fakhri
Won Seog Kim
Minal A Barve
Jonathon B Cohen
Wojciech Jurczak
Talha Munir
Meghan C Thompson
Donald E Tsai
Katherine Bao
Nicholas A Cangemi
Jennifer F Kherani
Richard A Walgren
Hongmei Han
Amy S Ruppert
Jennifer R Brown
Affiliated Authors:
Nicole Lamanna
Columbia Affiliation:
Subjects:
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
mTOR Signaling in Growth and Disease (OpenAlex Topic)
Efficacy and Resistance in CML Treatment (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.3324/haematol.2024.285754
PMID:
39363864
DOI:
10.3324/haematol.2024.285754
Journal:
Haematologica
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View OpenAlex Record
View Web of Science Record

Record Created: